tiprankstipranks

Richard Barry Insider Profile

11 Followers
Richard Barry, Director at Sarepta Therapeutics, holds 3.18M shares in Sarepta Therapeutics (Ticker: SRPT), holds 293.48K shares in Cassava Sciences (Ticker: SAVA), holds 3.34M shares in MiMedx Group (Ticker: MDXG).
tipranks
Richard Barry

Richard Barry
Sarepta Therapeutics (SRPT)
Director

Ranked #3,912 out of 98,501 Corporate Insiders

Profitable Transactions

82%
9 out of 11 Profitable Transactions

Average Return

+32.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$395M
93.22%
5.32%
1.46%
A breakdown of Richard Barry's holdings

Insider Roles

Sarepta Therapeutics
(SRPT)
Director
MiMedx Group
(MDXG)
Director
Cassava Sciences
(SAVA)
Director
Roles that Richard Barry holds in companies

Most Profitable Insider Trade

Stock:
Sarepta Therapeutics
(SRPT)
Rating:Informative Buy
Date:Mar 16, 2016 - Mar 16, 2017
Return:+108.50%
The most profitable trade made by Richard Barry

Richard Barry's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sarepta Therapeutics
Mar 05, 2024
Director
Uninformative Buy
$367.87M
MiMedx Group
Aug 06, 2020
Director
Uninformative Buy
$21.00M
Cassava Sciences
Aug 23, 2023
Director
Informative Buy
307.93K
$5.76M
List of latest transactions for each holding click on a transaction to see Richard Barry's performance on stock

Richard Barry insider profile FAQ

What is the percentage of profitable transactions made by Richard Barry?
The percentage of profitable transactions made by Richard Barry is 82%.
    What is the average return per transaction made by Richard Barry?
    The average return per transaction made by Richard Barry is 32.40%.
      What stocks does Richard Barry hold?
      Richard Barry holds: SRPT, MDXG, SAVA stocks.
        What was Richard Barry’s latest transaction?
        Richard Barry latest transaction was an Uninformative Buy of ―.
          What was Richard Barry's most profitable transaction?
          Richard Barry’s most profitable transaction was an Informative Buy of SRPT stock on March 16, 2016. The return on the trade was 108.50%.
            What is Richard Barry's role in Sarepta Therapeutics?
            Richard Barry's role in Sarepta Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.